INKT MiNK Therapeutics, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $47.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $27.6K | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $422.2K | $95.0K |
| 2023-Q3 | $325.9K | $0 |
| 2023-Q4 | $41.6K | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $27.5K |
| 2026-Q2 | $0 | $19.1K |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $73.3K |
Bought$817.2K15 buy days
Sold$214.9K7 sell days
Net insider flow+$602.4Knet buying · 5 years
Latest trade2026-10-12Buell Jennifer
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Sell | Buell Jennifer | CEO | 6,938 | $10.56 | $73.3K | 1 |
| 2026-06-04 | Sell | Ryan Barbara | Director | 1,500 | $12.76 | $19.1K | 2 |
| 2026-03-10 | Sell | Ryan Barbara | Director | 1,300 | $15.40 | $20.0K | 3 |
| 2026-03-09 | Sell | Ryan Barbara | Director | 200 | $10.17 | $2.0K | 1 |
| 2026-03-02 | Sell | Ryan Barbara | Director | 100 | $10.83 | $1.1K | 1 |
| 2026-02-27 | Sell | Ryan Barbara | Director | 400 | $10.86 | $4.3K | 1 |
| 2023-10-16 | Buy | AGENUS INC | 10% owner | 429 | $1.10 | $472 | 1 |
| 2023-10-13 | Buy | AGENUS INC | 10% owner | 19,373 | $1.10 | $21.3K | 1 |
| 2023-10-12 | Buy | AGENUS INC | 10% owner | 3,173 | $1.10 | $3.5K | 1 |
| 2023-10-04 | Buy | AGENUS INC | 10% owner | 15,001 | $1.09 | $16.4K | 1 |
| 2023-08-29 | Buy | AGENUS INC | 10% owner | 29,678 | $1.52 | $45.1K | 1 |
| 2023-08-28 | Buy | AGENUS INC | 10% owner | 12,808 | $1.45 | $18.6K | 1 |
| 2023-08-24 | Buy | AGENUS INC | 10% owner | 170,244 | $1.54 | $262.2K | 1 |
| 2023-05-11 | Buy | AGENUS INC | 10% owner | 23,361 | $1.43 | $33.4K | 1 |
| 2023-05-10 | Buy | AGENUS INC | 10% owner | 22,065 | $1.51 | $33.3K | 1 |
| 2023-05-05 | Buy | AGENUS INC | 10% owner | 100,200 | $0.95 | $95.2K | 2 |
| 2023-05-05 | Sell | ARMEN GARO H | Director | 100,000 | $0.95 | $95.0K | 1 |
| 2023-05-04 | Buy | AGENUS INC | 10% owner | 21,473 | $1.22 | $26.2K | 1 |
| 2023-05-03 | Buy | AGENUS INC | 10% owner | 128,689 | $1.08 | $139.0K | 1 |
| 2023-05-02 | Buy | ARMEN GARO H | Director | 100,000 | $0.95 | $95.0K | 1 |
| 2022-07-19 | Buy | WIINBERG ULF | Director | 16,661 | $1.39 | $23.2K | 1 |
| 2022-07-18 | Buy | WIINBERG ULF | Director | 3,339 | $1.33 | $4.4K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| AGENUS INC | 10% owner | $694.6K | $0 | 2023-10-16 |
| ARMEN GARO H | Director | $95.0K | $95.0K | 2023-05-05 |
| Buell Jennifer | CEO | $0 | $73.3K | 2026-10-12 |
| Ryan Barbara | Director | $0 | $46.6K | 2026-06-04 |
| WIINBERG ULF | Director | $27.6K | $0 | 2022-07-19 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.